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Abstract
Introduction—We examine the prevalence of depression and obesity, and metabolic syndrome, 
in a population-based cohort of Mexican Americans living on the US/Mexico border.
Methods—We analyzed extensive clinical and laboratory data from 1798 Mexican Americans 
aged 35 to 64 years. Depression was measured using the Center for Epidemiological Studies –
Depression (CES-D) scale. Weighted data were analyzed to establish prevalence of obesity, 
metabolic syndrome and Depression. Univariate and multivariate weighted regression models were 
used to test potential associations between these disorders.
Results—Using weighted prevalence methods, we found high rates of obesity (51%) metabolic 
syndrome (46%) and depression (29%). The most consistent risk for depression was associated 
with female gender. Metabolic syndrome was not associated with depression; however we found 
significant increased risk for two subcomponents, Low HDL and increased waist circumference. 
Severe obesity was significantly associated with both mild and severe depression.
Conclusions—In this large population-based sample of Mexican-Americans, we observed 
significant associations between obesity related biomarkers and depression that may be targets for 
public health interventions.
The prevalence of obesity in the US has reached epidemic proportions affecting over 30% of 
the adult population over the age of 18 1, 2. Worldwide, obesity has a tremendous economic 
burden 3, 4 with roughly $147 billion dollars in costs attributed to obesity and related health 
conditions annually 5. In addition to the economic burden to society, there is extensive 
evidence linking obesity to poor physical outcomes in particular cardiovascular disease, 
hypertension, stroke, obstructive sleep apnea, and type-2 diabetes 3. Obesity is also a 
contributor to metabolic syndrome 6 which is a clustering of major cardiovascular risk 
factors that include a constellation of atherogenic dyslipidemias, elevated blood pressure, 
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increased waist circumference and elevated glucose 7. In terms of mental health, obesity and 
metabolic syndrome have been associated with poorer outcomes particularly in regards to 
depression 3, 8–10
The significant but modest association between obesity and depression has been replicated 
in many studies 9, 11. A meta-analyses of cross sectional community studies revealed an 
odds ratio of 1.18 (95% CI 1.01–1.37)11 and a meta-analyses of longitudinal studies 
estimated the odds ration to be 1.58 (95% CI 1.33–1.87). The mechanisms for the co-
occurrence of these disorders is complex with proposed biological components such adipose 
induced inflammation 12, 13, Hypothalamic-Pituitary- Adrenal (HPA) alterations 14 and 
psychosocial factors such as stigma and low self esteem 15 all identified as potential 
contributors.
Hispanics now comprise the largest ethnic-minority group residing in the United States 
accounting for 15% of the population and over 46 million people 16, with depression as the 
most common mental illness in this ethnic group 17–19. Existing studies suggest that obesity 
and depression are highly prevalent among Hispanic populations 20, 21, 22. Within Latino/
Hispanic populations, Mexican-Americans (MA), who number over 31 million, are the 
largest single subgroup and the fastest growing ethnic group in the U.S. with a 54% increase 
between 2000 and 2010 16. Alarmingly, recent reports of MA populations estimate the 
prevalence of obesity to be between 50%–70% 1, 23, 24. With the increased prevalence of 
obesity, it is not surprising that obesity related sequelae such as cardiovascular disease 25–27 
diabetes 28–30 and metabolic syndrome have also been shown to be significantly more 
prevalent in MA populations 31. Given that depression has been associated separately with 
obesity 9 and metabolic syndrome10, examining the link between depression and obesity and 
metabolic syndrome in Mexican-Americans may have significant public health implications 
and provide a potential target for intervention.
Herein we examine the prevalence of depression and obesity, and metabolic syndrome, in a 
randomly selected population-based cohort of 1,798 Mexican Americans living on the US/
Mexico border as part of a larger Cameron County Hispanic Cohort: (CCHC) 24. Within the 
whole cohort (n= 2583), we have observed the prevalence of obesity (48.5%)24, and 
metabolic syndrome (43%)27, 31 occurring at epidemic proportions and linked with a host of 
other health conditions.
Study population
These participants were recruited between the years 2004–2010, as part of the CCHC 24. 
Subjects were selected with stratified two-stage random sampling based on the 2000 census 
tract data in the city of Brownsville, Texas, situated on the US–Mexico border. This cohort is 
predominantly Mexican-American (>98%). Willing participants completed a comprehensive 
questionnaire regarding basic demographic information, medical history, medication use, 
and social and family history as described previously 24. Our sample is predominantly 
female n = 1181 (66%) with a mean age of 44.3 (±15.40) that does not differ between 
genders.
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Depression was measured using the Center for Epidemiological Studies –Depression (CES-
D) a 20-item scale developed for epidemiologic studies of depressive symptoms in the 
general population with a cutoff score of ≥ 16 being suggestive of depression 32. Consistent 
with prior studies 33, we further classified individuals as mildly depressed if their CES-D 
score was 16–26, and severely depressed if their score was ≥ 27. As described previously 24, 
body mass index (BMI) for each subject was calculated based on measured height and 
weight with their shoes removed by using a portable electronic scale and recorded to the 
nearest 0.2 kg and height measured to the nearest 0.2 cm by using a stadiometer. We 
categorized BMI scores as obese (≥30 kg/m2) and later subdivided the obese subjects as 
mildly obese (≥30 – 39 kg/m2) and severely obese (BMI ≥40 kg/m2). Metabolic syndrome 
was defined using the American Heart Association definition 7, which requires the presence 
of at least three of the following: elevated waist circumference, ≥ 102 cm or 40 inches for 
men or ≥ 88 cm or 35 inches for women; elevated triglycerides ≥150 mg/dl; reduced High 
density lipoprotein (HDL) cholesterol ≤ 40 mg/dl for men or, 50 mg/dl for women; elevated 
blood pressure ≥ 130/85 mm Hg or use of medication for hypertension; and elevated fasting 
glucose ≥ 100 mg/dl. Blood samples were taken and aliquots immediately stored at −70°C 
for a range of clinical and experimental assays. Blood glucose measurement was performed 
on site and stored specimens were sent in batches to a CLIA approved clinical laboratory for 
clinical chemistries. All participants provided written informed consent and this study has 
been approved by the Institutional Review Board of the University of Texas Health Science 
Center at Houston.
Statistical analysis
From the original cohort of 2,583 subjects, 1,798 had complete data and were included in 
this study. These 1,798 subjects did not differ from the original cohort in terms of age and 
gender status. To correct the imbalance of the sampling ratios of genders and age groups, 
and to adjust the sample to population scale, we incorporated age and gender adjusted 
sampling weights into our analysis as fully described previously 24. In addition to the 
sampling weights adjustments, in the analysis we took into account the potential clustering 
(correlated data) among subjects within the same household and subjects within the same 
census blocks. All analyses were performed using SAS version 9.1 (SAS Institute, Inc, Cary, 
North Carolina) and Stata 10 SE (StataCorp LP, College Station, Texas), with adjustments in 
the respective statistical packages for sampling design. For descriptive purposes, 
demographic and clinical characteristics were analyzed using chi-square and F-tests for 
categorical and continuous variables across the depression strata. Data are presented as 
weighted means (SE) for continuous variables and as frequencies and unweighted and 
weighted percentages for categorical variables. Univariate analysis with weighted logistic 
regression was performed in order to examine obesity, cholesterol and metabolic syndrome 
and demographic characteristics and estimate the odds ratios depression compared to non-
depressed subjects. The variables that had a statistically significant effect at < 0.05 level in 
the univariate analyses were examined in multivariable logistic regression model. Given that 
prior work has noted gender differences in regards to metabolic outcomes 31, 34, and 
depression 35 we explored the potential effects of these variables separately for males and 
females. In addition, we focused on cases with more severe clinical presentation as this may 
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reduce heterogeneity and has been a useful strategy in biomarker research 36–38. We 
therefore used a similar analytic strategy to further explore severe obesity and severe 
depression as our phenotypes.
Results
Using weighted prevalence methods, half of our total sample (52%) was obese. We further 
classified 44% of the sample as mildly obese and 7% as severely obese with BMI ≥ 40. We 
also found 46% of these subjects met criteria for metabolic syndrome. For depression, 29% 
of the sample had CES-D scores in the clinically significant range ≥ 16 with 15% classified 
as mildly depressed (CES-D scores 16–26), and 14% severely depressed (CES-D scores ≥ 
27) (See Table 1).
Comparing our measures in the sample by gender also found significantly higher mean 
CESD depression scores in females (F1, 1052 = 27.61, p< 0.0001). We also found a 
significantly higher percentage of females with depression (34.4%) (F1, 1052 = 13.21, p= 
0.0003 using a weighted analysis. There was no statistical significant difference of mean 
BMI or percentage metabolic syndrome between females and males, however more males 
had elevated triglycerides (51.2%) (F1, 1052 = 9.12, p= 0.0026), more males had elevated 
glucose (50.9%) (F1, 1052 = 8.87, p= 0.003), and more females had low HDL (60%)((F1, 1052 
= 19.8, p<0.0001), and increased waist circumference (78.5%) (F 1, 1052 = 25.76, p<0.0001) 
(see Table 1).
Using separate weighted univariate logistic regression we examined the broad CES-D cutoff 
for Depression (CESD score ≥ 16) for age, gender, obesity, cholesterol, metabolic syndrome 
and it subcomponents. We found that higher risk for depression was associated with female 
gender (OR=2.28; 95%CI 1.46– 3.56) as seen in Table 2. When we examined the 
subcomponents of metabolic syndrome separately, low HDL (OR=1.64; 95%CI1.34–2.01) 
and increased waist circumference (OR=1.63; 95%CI 1.05–2.53) had significantly higher 
odd’s ratios for depression (Table 2) and these remained significant when adjusting for age 
(Table 2 Model 2). In a Multivariate analyses including age, gender, low HDL, and waist 
circumference, only the higher odds ratio for depression by female gender (OR=2.03; 
95%CI 1.34–3.10) remained significant (Table 2, Model 3). No significant statistical 
interaction between the variables was found.
Using a similar strategy in multivariate multivariable weighted logistic regression we 
explored potential associations between our extreme phenotypes including moderate (CESD 
score ≥ 16 < 27) and severe depression (CESD score ≥ 27) as well as mild obesity (BMI 
score ≥ 30 < 40) and severe obesity (BMI score ≥ 40). In these analyses we found significant 
associations for female gender as a predictor of mild (OR = 1.79; 95% CI 1.17–2.73) and 
severe depression (OR = 3.09; 95% CI 1.29 –7.36) which remained significant when 
controlling for age (as seen in Table 3, Models 1 and 2). In these analyses severe obesity was 
also a significant predictor of mild (OR = 2.31; 95% CI 1.34 – 4.01) and severe depression 
(OR = 2.68; 95% CI 1.47 – 4.89) (as seen in Table 3, Models 1 and 2). Although metabolic 
syndrome was not a predictor of depression, when we examined the subcomponents of 
metabolic syndrome separately, low HDL (OR = 1.61; 95% CI 1.08 – 2.38) and increased 
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waist circumference (OR = 1.68; 95% CI 1.10 –2.56) had significantly elevated odd’s ratios 
for mild depression and these same factors remained unchanged when adjusting for age 
(Table 3). We then including these risk factors in a multivariate model however we excluded 
increased waist circumference as 99% of our severely obese subjects also had elevated waist 
circumference. This strategy revealed female gender (OR = 2.89; 95% CI 1.46–5.74), being 
severely obese (OR = 2.31; 95% CI 1.26–4.25), and having low HDL (OR = 1.50; 95% CI 
1.00–2.26), were all significantly associated with increased risk for severe depression (see 
Table 3).
Examining significant factors separately by gender revealed that severe obesity (OR = 2.79; 
95% CI 1.40–5.54), and increased waist circumference (OR = 2.11; 95% CI 1.11–4.01), 
were statistically significant for females as predictors of severe depression, and severe 
obesity (OR = 2.91; 95% CI 1.53–5.52), and Low HDL (OR = 1.60; 95% CI 1.02–2.49), 
were significant as predictors for mild depression in females. For males no single variable 
significantly predicted mild or severe depression.
Discussion
In this large randomly selected population-based sample of Mexican-Americans, we 
observed an alarmingly high prevalence of depression (29 %) and putative risk factors, of 
obesity (51%), and metabolic syndrome (45%). These prevalence rates are all greater than 
national estimates of depression (9%) 39, obesity (33%) 1 and metabolic syndrome (22%) 40 
suggesting a particular vulnerability in our cohort.
Our most consistent finding that females were observed to have higher levels of depression 
regardless of the cutoff used, is in line with a large body of depression literature 35, 41, 42. 
The explanation for increased depression in women seems to be multi-factorial with puberty 
and associated sex hormone changes 43 as well as stress-reactivity, thyroid hormones, pre-
existing anxiety, response styles and stress associated with gender roles as possible 
contributing factors 35.
As noted by prior studies obesity and increased waist circumference were also noted as risk 
factors for depression 44–47. In our cohort these anthropomorphic findings were especially 
noteworthy when we examined severe depression and were largely driven by severely obese 
females. Our findings mirror other studies that note women 11, 20, 48 with severe obesity 
20, 48 are at particularly high risk for depression. Although not significant in our sample, the 
relationship between metabolic syndrome and depression has been reported to be stronger in 
women 49, 50.
Given the common co-occurrence of obesity and depression, a causal relationship between 
these disorders can be difficult to untangle 11, 51. In a study of the temporal relationship 
between obesity and depression, depressed subjects who were not obese at baseline were not 
more likely to become obese than were non-depressed subjects, however obese subjects 
without baseline depression, were twice as likely to develop depression during the 5-year 
period compared to non-obese subjects 46 suggesting obesity precedes depressive symptoms. 
However recent meta-analytic studies examining longitudinal studies find the relationship 
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between obesity and depression to be bidirectional 52. For example eight studies found 
obesity at baseline increased the risk of onset of depression at follow-up (OR=1.55; 95% CI 
1.22–1.98) and nine studies found depression increased the odds for developing obesity 
(OR= 1.58; 95% CI, 1.33–1.87) 52. One putative mechanism for the relationship between 
obesity and depression is the secretion by adipocytes of adipocytokines such as(Interleukin 
(IL)-1b, IL-6, IL-8, IL-10, TNF-a, TGF-b,) resulting in a state of chronic low level 
inflammation in obese subjects 12. These pro-inflammatory cytokines cross the blood brain 
barrier and can directly influence brain physiology which may contribute directly to the 
development of depressive symptoms 12, 1353. Conversely, the HPA axis activation seen in 
depression marked by increased cortisol 54 may induce abdominal obesity 55. Additionally 
we recently reported significant but negative genetic correlations between BMI and cortical 
and subcortical regions suggesting the same genetic factors that increase BMI could lead to 
decreases in brain anatomy 56.
Although Metabolic syndrome was not a significant predictor of depression in our sample 
two subcomponents of metabolic syndrome Low HDL and increased waist circumference 
were. Low HDL is known for its associated cardiovascular risk 57, 58 and it has also been 
linked with depression 59, 60. Of interest low HDL’s purported cardiovascular risk effects are 
believed to be due to a loss of the anti-inflammatory and antioxidative properties of HDL-C 
58, 61. This mechanism is consistent with the hypothesis linking increased inflammatory 
markers to depression 12, 53, 62, and may account our findings associating depression with 
low HDL.
The ramifications of obesity are major public health issues in America. Lifestyle changes 
such a healthy diet and increased physical activity are the accepted interventions for 
addressing obesity 63, and are reported to have beneficial effects in decreasing depressive 
symptoms 64. However promoting a healthy diet and increased physical activity is difficult 
65 and will require a concerted effort across multiple domains. These will include altering 
environmental factors that promote unhealthy food, improved healthcare approaches, 
government policies, and improved access to environments for physical activity 6663. The 
cohort described above with increased obesity, metabolic syndrome, and depression may be 
particularly vulnerable as they are of lower SES, and few have medical coverage 24 and thus 
unmet medical needs 27. Given that there is considerable evidence of inadequate mental 
health care needs in Mexican Americans 67, 68 addressing these issues may be daunting 
requiring a comprehensive, adaptable community oriented design 69.
This study is cross sectional in nature therefore cannot address the issues of causality or 
directionality. This cohort also consisted primarily of women, was of lower SES and the 
majority (70%) preferred to respond in Spanish which raises issues of acculturation, and 
gender that were not the primary focus of this study. Although depression was not the 
primary focus of this study, the CES-D is a well accepted measure of depressive symptoms 
in a population32, 70, however it does not follow strict DSM criteria, cannot establish 
chronicity and number of episodes and does not account for confounding or co-morbid 
psychiatric conditions. Despite these limitations the breadth and sample size of this study 
allow for exploration based on gender, and multiple risk factors such as severe depression 
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Table 1
Demographic and Clinical Variables by Gender represented by weighted means and their SE for continuous 







Age 44.30 (0.74) 41.52 (1.23) 43.33 (0.69)
BMI 30.84 (0.36) 31.09 (0.32) 30.93 (0.26)
CESD score 14.01 (0.67) *** 8.75 (0.76) 12.18 (0.52)
Obese: BMI ≥30 630 (53.3%) 300 (48.6%) 930 (51.7%)
Weighted % (49.3%) (54.4%) (51.1%)
 Subcategories
 BMI ≥30–39 519 (43.9%) 258 (41.8%) 777 (43.2%)
Weighted % (40.7%) (49.5%) (43.7%)
 BMI ≥40 111 (9.4%) 42 (6.8%) 153 (8.5%)
Weighted % (8.7%) (4.9%) (7.3%)
Metabolic Syndrome 552 (46.7%) 260 (42.1%) 812 (45.2%)
Weighted % (46.9%) (42.8%) (45.5%)
Sub components
 Hypertension 260 (22.0%) 155 (25.1%) 415 (23.1%)
 Weighted % (21.3%) (27.1%) (23.3%)
 Elevated Triglycerides 418 (35.3%) 311 (50.4%) 729(40.5%)
 Weighted % (37.9%) (51.2%)** (42.5%)
 Elevated Glucose 486 (41.1%) 314 (51.0%) 800 (44.4%)
 Weighted % (38.9%) (50.9%)** (43.1%)
 Low HDL 708(60.0%) 251(41.0%) 959 (53.3%)
 Weighted % (60.6%)** (41.7%) (54.1%)
 Waist Circumference 957 (81.0%) 340(55.1%) 1297(72.1%)
 Weighted % (78.5%)*** (57.8%) (71.4%)
Depression 418 (35.4%) 116(18.8%) 534(29.7%)
 Weighted % (34.4%)*** (18.8%) (28.9%)
 Subcategories
 Mild 218 (18.5%) 80 (13.0%) 298 (16.6%)
 Weighted % (16.7%) (11.6%) (14.9%)
 Severe 200 (16.9%) 36 (5.8%) 236 (13.1%)
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Table 2
Weighted Odds Ratios a and 95%CI for Depression and Selected Risk Factors
Risk Factors Unadjusted OR (95% CI) Model 2 Adjusted for age (95% CI) Model 3 b (95% CI)
Age 1.01 (0.99–1.02) 1.00 (0.99–1.02)
Female 2.28 (1.46 –3.56) 2.26 (1.46–3.49) 2.03 (1.34–3.10)
Obesity 1.02 (0.73–1.44)
Cholesterol 1.00 (0.99 –1.01)
Metabolic Syndrome 1.22 (0.87–1.73)
Metabolic Syndrome Components
Hypertension 0.98 (0.68, 1.43)
Triglycerides 0.89 (0.62, 1.26)
Elevated Glucose 1.01 (0.72, 1.41)
Low HDL 1.64 (1.34–2.01) 1.61 (1.11–2.33) 1.39 (0.96–1.02)
Waist Circumference 1.63 (1.05 –2.53) 1.60 (1.03–2.49)
a
reference category compared to Non-depressed
b
HDL, Waist Circumference, Gender and Age in the model
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Table 3
Weighted Odds Ratios a and 95%CI for Depression and Selected Risk Factors
Risk Factors Unadjusted OR (95% CI) Model 2 Adjusted for age (95% CI) Adjusted OR b (95% CI)
Age
 Mild depression 1.01 (0.99–1.02) 1.01 (0.99–1.02)
 Severe depression 1.01 (0.99–1.02) 1.01 (0.99–1.02)
Female
 Mild depression 1.79 (1.17–2.73) 1.76 (1.17–2.67) 1.42 (0.90–2.24)
 Severe depression 3.09 (1.29–7.36) 3.06 (1.31–7.15) 2.89 (1.46–5.74)
Severe Obesity (BMI>=40)
 Mild depression 2.31 (1.34–4.01) 2.29 (1.33–3.96) 1.96 (1.13–3.41)
 Severe depression 2.68 (1.47–4.89) 2.66 (1.47–4.81) 2.31 (1.26–4.25)
Cholesterol
 Mild depression 1.00 (0.99–1.002)
 Severe depression 1.00 (0.99–1.004)
Metabolic Syndrome
 Mild depression 1.14 (0.79–1.66)
 Severe depression 1.33 (0.79–2.25)
Metabolic Syndrome Components
Hypertension
 Mild depression 1.15 (0.76–1.76)
 Severe depression 0.82 (0.49–1.39)
Triglycerides
 Mild depression 0.70 (0.48–1.02)
 Severe depression 1.12 (0.68–1.86) 1.09 (0.60–1.98) 1.25 (0.56–2.80)
Elevated Glucose
 Mild depression 1.01 (0.70–1.45)
 Severe depression 1.00 (0.61–1.66)
Low HDL
 Mild depression 1.61 (1.08–2.38) 1.61 (1.08–2.39) 1.50 (1.00–2.26)
 Severe depression 1.61 (0.91–2.86) 1.61 (0.91–2.87) 1.29 (0.72–2.29)
Waist Circumference
 Mild depression 1.68 (1.10–2.56) 1.65 (1.06–2.56)
 Severe depression 1.58 (0.78–3.21) 1.55 (0.78–3.10)
a
reference category compared to Non-depressed
b
adjusted with other factors in model
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